[HTML][HTML] The dichotomous role of immunoproteasome in cancer: Friend or foe?
B Chen, H Zhu, B Yang, J Cao - Acta Pharmaceutica Sinica B, 2023 - Elsevier
Immunoproteasome is a variant of proteasome with structural differences in 20S subunits
optimizing them for the production of antigenic peptides with higher binding affinity to major …
optimizing them for the production of antigenic peptides with higher binding affinity to major …
The dichotomous role of immunoproteasome in cancer: Friend or foe?
B Chen, H Zhu, B Yang, J Cao - Acta Pharmaceutica Sinica. B, 2022 - europepmc.org
Immunoproteasome is a variant of proteasome with structural differences in 20S subunits
optimizing them for the production of antigenic peptides with higher binding affinity to major …
optimizing them for the production of antigenic peptides with higher binding affinity to major …
The dichotomous role of immunoproteasome in cancer: Friend or foe?
B CHEN, H ZHU, B YANG… - Acta Pharmaceutica Sinica …, 2023 - pesquisa.bvsalud.org
Immunoproteasome is a variant of proteasome with structural differences in 20S subunits
optimizing them for the production of antigenic peptides with higher binding affinity to major …
optimizing them for the production of antigenic peptides with higher binding affinity to major …
[HTML][HTML] The dichotomous role of immunoproteasome in cancer: Friend or foe?
B Chen, H Zhu, B Yang, J Cao - Acta Pharmaceutica Sinica. B, 2023 - ncbi.nlm.nih.gov
Immunoproteasome is a variant of proteasome with structural differences in 20S subunits
optimizing them for the production of antigenic peptides with higher binding affinity to major …
optimizing them for the production of antigenic peptides with higher binding affinity to major …
The dichotomous role of immunoproteasome in cancer: Friend or foe?
B Chen, H Zhu, B Yang, J Cao - Acta pharmaceutica …, 2023 - pubmed.ncbi.nlm.nih.gov
Immunoproteasome is a variant of proteasome with structural differences in 20S subunits
optimizing them for the production of antigenic peptides with higher binding affinity to major …
optimizing them for the production of antigenic peptides with higher binding affinity to major …
The dichotomous role of immunoproteasome in cancer: Friend or foe?
B Chen, H Zhu, B Yang, J Cao - Acta Pharmaceutica Sinica. B, 2022 - europepmc.org
Immunoproteasome is a variant of proteasome with structural differences in 20S subunits
optimizing them for the production of antigenic peptides with higher binding affinity to major …
optimizing them for the production of antigenic peptides with higher binding affinity to major …
The dichotomous role of immunoproteasome in cancer: Friend or foe?
C Boya, ZHU Haiying, Y Bo… - … Pharmaceutica Sinica B, 2023 - pesquisa.bvsalud.org
Immunoproteasome is a variant of proteasome with structural differences in 20S subunits
optimizing them for the production of antigenic peptides with higher binding affinity to major …
optimizing them for the production of antigenic peptides with higher binding affinity to major …